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A B S T R A C T
Percutaneous transcatheter aortic valve implantation (TAVI), ﬁrst introduced in 2002, is a viable solution
for previously inoperable or high-risk patients with aortic stenosis, providing the beneﬁt of valve
replacement without the associated risks of surgery. When these patients develop prosthetic valve
endocarditis (PVE), management is complicated, owing to their often, atypical presentations and
baseline comorbidities. Moreover, it is often difﬁcult to detect vegetations in such patients, even with
transesophageal echocardiography. Here, we describe a case of post-TAVI PVE that was successfully
treated medically after a rapid diagnosis was made based on physical examination. Our experience
shows that physical examination continues to be important for rapid diagnosis of infective endocarditis,
even in the era of structural heart disease intervention.
<Learning objective: Diagnosis of endocarditis in transcatheter aortic valve implantation patients can
be difﬁcult and may be delayed, as echocardiography is often inconclusive because of the unique
physiology of these patients. We should maintain a low threshold for investigation of infective
endocarditis in these patients, and more emphasis should be placed on physical examination to ensure
rapid diagnosis and favorable clinical outcome.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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In 2002, percutaneous transcatheter aortic valve implantation
(TAVI) was ﬁrst introduced as a viable solution for inoperable or
high-risk patients with severe symptomatic aortic stenosis (AS)
[1]. As TAVI became widespread, prosthetic valve endocarditis
(PVE) began to draw notice as a critical potential sequela [2]. In a
study of the largest multicenter registry of TAVI patients, the rate of
PVE was 0.67% after 1.1 years of follow-up, similar to that among
patients who underwent surgical aortic valve replacement. Howev-
er, the 1-year mortality rate associated with post-TAVI PVE was 66%,
which is higher than for any other kind of infective endocarditis (IE)
[3]. TAVI patients often have multiple comorbidities, which can* Corresponding author at: Department of Cardiology and Catheterization
Laboratory, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura,
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1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightssigniﬁcantly complicate management and increase PVE morbidity
and mortality [4,5]. Rapid diagnosis with appropriate treatment is
crucial for these patients, but the presence of multiple comorbidities,
along with the prosthetic nature of the implanted valve, may make
this difﬁcult. We here describe a case of PVE after implantation of a
CoreValve prosthetic valve (Medtronic, St Paul, MN, USA) that was
successfully treated as a result of rapid diagnosis based on physical
examination.
Case report
The patient was a 79-year-old male emergently admitted to our
hospital with persistent fever, disturbance of consciousness, and
malaise. He had a history of chronic lung disease and coronary
artery bypass surgery for angina, and 20 months prior to
presentation, he had undergone transfemoral TAVI with a 29-
mm Medtronic CoreValve prosthesis for severe symptomatic aortic
stenosis. He had type II diabetes mellitus and denied the presence
of common risk factors associated with IE, including recent dental reserved.
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On admission, he appeared generally ill, with a temperature of
39.3 8C, a Glasgow Coma Scale score of 13, and a blood pressure of
154/80 mmHg. Initial laboratory tests showed leukocytosis with a
predominance of neutrophils, as well as an elevated C-reactive
protein level (21.6 mg/dL). Transthoracic echocardiography (TTE)
showed no obvious vegetation and only trivial paravalvular aortic
regurgitation, with no signiﬁcant changes compared with the
original post-TAVI TTE. T2-weighted brain magnetic resonance
imaging (MRI) showed only age-appropriate old lacunar infarcts in
the right caudate nucleus. On the second hospital day, physical
examination revealed Janeway lesions on the ﬁngers (Fig. 1), but no
conjunctival hemorrhage, Osler’s nodes, or Roth’s spots. Transe-
sophageal echocardiography (TEE) did not show any obvious
vegetation (Fig. 2).
Although the patient did not fulﬁll any of the major modiﬁed
Duke criteria for IE, 3 minor criteria (a fever of 39 8C, the
predisposing effect of the prosthetic valve, and Janeway lesions)
were present, indicating its possibility. Therefore, intravenous
administration of vancomycin and gentamicin was initiated
immediately. On the third hospital day, 3 of 4 blood cultures
taken on the admission day were found to be positive for
methicillin-susceptible Staphylococcus aureus, and vancomycin
was switched to cefazolin. On the fourth hospital day, diffusion-
weighted brain MRI showed high signal intensity in the bilateral
frontal lobe and cerebellar hemisphere (Fig. 3), which suggestedFig. 1.
(A) A Janeway lesion can be seen on the right index ﬁnger (black arrow).
(B) Janeway lesions are evident on the pad of the left middle ﬁnger
(black arrow).multiple acute cerebral infarcts caused by embolisms. A second
TEE, performed 2 weeks after admission, showed mobile vegeta-
tion on the leaﬂets of the aortic prosthesis but indicated a well-
functioning prosthetic valve with trivial paravalvular aortic
regurgitation (Fig. 2). A third TEE, 3 weeks after admission,
conﬁrmed resolution of the vegetation without impaired prosthe-
sis function. A series of MRIs found no obvious endocarditis-related
cerebral aneurysms. The clinical outcome was good, with
resolution of the fever, return to normal levels of inﬂammatory
markers, and disappearance of the peripheral stigmata of IE. After
6 weeks of intravenous cefazolin, the patient was discharged. Over
a follow-up period of 1 year, there was no recurrence of PVE.
Discussion
The clinical course of the present patient provided important
clinical suggestions regarding post-TAVI PVE. Our ﬁndings
suggested that the modiﬁed Duke criteria for IE might also be
useful for the diagnosis of post-TAVI PVE; however, detecting
vegetation, even with TEE, is often difﬁcult in such patients.
Physical examination is important and especially critical for rapid
diagnosis. In this case, the presence of Janeway lesions was an
excellent clue to the diagnosis and aided in the successful
treatment of our patient.
The number of TAVI procedures performed yearly worldwide
has grown exponentially since the ﬁrst TAVI was performed in
2002 [1], making post-TAVI PVE an increasingly important
problem. Surgical intervention is not feasible in the majority of
post-TAVI PVE patients owing to their multiple comorbidities. A
recent study reported that at least 1 complication requiring
reintervention according to the guidelines occurred in 86.8% of
patients with post-TAVI PVE, including systemic emboli in 12.2%.
However, the rate of reintervention was as low as 11.3%—one of the
lowest rates of reintervention in PVE cases ever reported—and the
in-hospital mortality rate was 47.2%, which increased to 66% at the
1-year follow-up [3]. Thus, a delay in diagnosis can be disastrous.
The modiﬁed Duke criteria for IE may well be useful for the
diagnosis of post-TAVI PVE, although no study has yet conﬁrmed
their usefulness. However, our experience demonstrates that signs
visible on echocardiograms are not always necessary to make a
diagnosis. Furthermore, as mentioned above, detecting vegetations
with echocardiography, especially small ones, can be quite difﬁcult
in TAVI patients; it has been reported that the sensitivity and
speciﬁcity of TEE and TTE for the diagnosis of IE are lower in
patients with prosthetic valves than in those with native valves
[6]. In the TAVI procedure, the calciﬁed native valve is not removed,
and the native leaﬂets are compressed in the Valsalva sinus.
Moreover, reﬂectance and shadowing due to aortic root calciﬁca-
tion and the metal frame of the prosthesis make it difﬁcult to
detect vegetations echocardiographically in TAVI patients, even
with TEE. A large multicenter registry reported that echocardio-
graphic ﬁndings revealed the presence of vegetations in only 77%
of patients with post-TAVI PVE; however, this rate may have been
overestimated because doubtful cases were not included [3].
Fever (71.7%) and heart failure (58.5%) have been reported to be
the most common symptoms of IE [3]. Additionally, peripheral
stigmata are less frequent than they once were [7,8], with Janeway
lesions present in 2.4–4.6% of cases, Osler’s nodes in 2.9–4.4% of
cases, Roth’s spots in 1.3–1.9% of cases, and splinter hemorrhages in
8.0% of cases [7,9]. However, these prevalence rates may be
underestimated, as standard procedures do not include systematic
dermatological examinations or photography for retrospective
assessment [8]. In the present case, the patient’s Janeway lesions,
which were visible before IE were conﬁrmed by echocardiography
and MRI, were a critical clue, enabling rapid diagnosis and successful
treatment. Our experience shows that physical examination for
Fig. 2.
(A and B) The ﬁrst transesophageal echocardiography (TEE), performed on the second hospital day, did not show any obvious vegetation. (C and D) A second TEE,
performed 2 weeks after admission, conﬁrmed mobile vegetation on the leaﬂets of the aortic prosthesis but indicated a well-functioning prosthetic valve with
trivial paravalvular aortic regurgitation (white arrows). LA, left atrium; LV, left ventricle; Ao, aorta.
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Fig. 3.
(A–C) Diffusion-weighted brain magnetic resonance images on the fourth hospital day showed bright signal intensity in the bilateral frontal lobe and cerebellar
hemisphere (white arrows).
T. Ochiai et al. / Journal of Cardiology Cases 13 (2016) 63–6666peripheral stigmata continues to be important for rapid diagnosis of
IE, particularly post-TAVI PVE, even in the era of structural heart
disease intervention.
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